Respiratory Diseases Call for Special Attention from Clinical and Translational Science
PharmD Nihal El Rouby,MD Arianna Pani,MD Christopher P. Austin,PhD Viswanath Devanarayan,Sharon F. Terry,Genetic Alliance,Alaina Webster,Aimee Greene,MD John A. Wagner,PhD Deanna L. Kroetz,MStat Qi Liu,P. M. Michael A. Pacanowski,PhD Elvin T. Price,P. Ravenstijn,Heidelberg Germany Affi med GmbH,PhD Mohamed Shahin,PhD Merck Sonal Singh,MD Leiwei Wang,PhD Erica Woodahl,PhD Neeraj Gupta,MD David E. Gutstein,PhD Richard Hargreaves,MD Dan Hartman,MD Zeping Hu,PhD Sara C. Humphreys,PhD Elena S. Izmailova,Jing,PhD Abhay Joshi,PhD Rajesh Krishna,PhD Chakradhar Lagishetty,MD SeungHwan Lee,PhD MD Lichuan Liu,PharmD Justin Lutz,PhD Pooja Manchandani,PharmD Jeannine McCune,MD Matthew McLaughlin,Mohamed-Eslam F. Mohamed,PhD RPh,MD Briggs Morrison,PharmD Melanie Nicol,MD Min Soo Park,PhD AstraZeneca Herts UK Alex N. Phipps,MD Philippe Pinton,Ferring Pharmaceuticals PhD,Denmark Saileta Prabhu Kastrup,MD Daniel Rader,PhD Potomac MD Usa Anuradha Ramamoorthy,PhD Laura B. Ramsey,PhD Alexandre Ribeiro,PhD Matthew L. Rizk,PharmD Michelle A. Rudek,MD ScD Sebastian Schneeweiss,PharmD Meenakshi Srinivasan,PhD Tore B. Stage,PhD Stephani Stancil,PhD MorphoSys Boston MA Faith Stevison,PhD Rommel Tirona,PhD Fcp Karthik Venkatakrishnan,Jon Wagner,PhD Yow-Ming C. Wang,MD Saskia N. de Wildt,PhD Libin Xu,PhD Xinning Yang,PhD Sook Wah Yee,PhD Songmao Zheng,PhD Bayer Antoinette Ajavon-Hartmann,B. Ag,MD Mark Applebaum,PharmD Imke H. Bartelink,PharmD Satjit Brar,PhD Ulf Bredberg,PharmD Kim L. R. Brouwer,PhD Nageshwar Budha,Lakshmi Manasa,PharmD Sakuntala Chekka,PhD Eugene C. Chen,PharmD Joseph Chen,Xinhui “Heller”,PhD Chen,PhD Yougan Cheng,PhD Mph Leslie Dickmann,PhD Jasper Dingemanse,PhD Barthelemy Diouf,PharmD Brian Ferslew,PhD Jeffry Florian,MD Adam Frymoyer,PharmD Ryan Funk,PhD Andrea Gaedigk,PhD Narender R. Gavva,PhD Tobias Gerhard,PhD Yan Gong,Geert Jan,MD Groeneveld
DOI: https://doi.org/10.1186/2213-0802-1-1
2013-01-01
Translational Respiratory Medicine
Abstract:Respiratory diseases will become one of the top 3 leading causes of estimated mortality in 2020 and become about one third of total causes of estimated mortality. The journal of Translational Respiratory Medicine is a truly international, peer-reviewed journal devoted to the publication of articles on outstanding work with translational potentials between basic research and clinical application to understanding respiratory disease. Translational respiratory medicine will more focus on biomarker identification and validation in pulmonary diseases in combination with clinical informatics, targeted proteomics, bioinformatics, systems medicine, or mathematical science; on different translational strategies of cell-based therapy to clinical application to treat lung diseases; on targeted therapies in combination with personalized medicine; and on distant electronic medicine to monitor a large population of people's health. Translational Respiratory Medicine is an additional but unique opportunity for scientists and clinicians who work on pulmonary diseases to publish their outstanding findings, initiative results, and critical and perceptive opinions in the journal.